Inhaled corticosteroid use and its association with Pseudomonas aeruginosa infection in COPD
H. Shafiek (Alexandria, Egypt), J. Verdú (Palma de Mallorca, Spain), C. López-Causapé (Palma de Mallorca, Spain), A. Iglesias (Palma de Mallorca, Spain), L. Ramon-Clar (Palma de Mallorca, Spain), C. Juan (Palma de Mallorca, Spain), N. Toledo-Pons (Palma de Mallorca, Spain), A. Oliver (Palma de Mallorca, Spain), B. García Cosío Piqueras (Palma de Mallorca, Spain)
Source: Virtual Congress 2021 – Inhaled treatments for COPD: clinical trials and real-world studies
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Shafiek (Alexandria, Egypt), J. Verdú (Palma de Mallorca, Spain), C. López-Causapé (Palma de Mallorca, Spain), A. Iglesias (Palma de Mallorca, Spain), L. Ramon-Clar (Palma de Mallorca, Spain), C. Juan (Palma de Mallorca, Spain), N. Toledo-Pons (Palma de Mallorca, Spain), A. Oliver (Palma de Mallorca, Spain), B. García Cosío Piqueras (Palma de Mallorca, Spain). Inhaled corticosteroid use and its association with Pseudomonas aeruginosa infection in COPD. 798
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: